Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

CAPR vs CLYM: stock comparison and AI forecast

Capricor Therapeutics, Inc. (CAPR) and Climb Bio, Inc. (CLYM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

CAPR Capricor Therapeutics, Inc.

Market Cap
$500M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

CLYM Climb Bio, Inc.

Market Cap
$509M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CAPR · CLYM

Key facts

  • CAPR and CLYM have similar market capitalizations ($500M and $509M).
  • CAPR carries 0.50 times debt per unit of equity, against 0.04 times for CLYM.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCAPRCLYM
Market Cap$500M$509M
P/B Ratio2.03x2.23x
EPS$-2.39$-0.87
Book Value/Share$4.24$3.97
FCF/Share$-1.98–

Profitability & Margins

MetricCAPRCLYM
ROE-52.6%-26.0%
ROA-35.1%-25.1%
ROIC-40.2%-29.2%
Operating Margin-607.1%–
Net Margin-581.4%–
EBT Margin-570.6%–
Tax Rate0.0%0.0%

Financial Health

MetricCAPRCLYM
Current Ratio7.35x26.58x
D/E Ratio0.50x0.04x
Financial Leverage1.50x1.04x
Interest Coverage-40.9x–
Working Capital$209M$202M

Cash Flow

MetricCAPRCLYM
Operating Cash Flow-$104M-$53M
Free Cash Flow-$115M–
Capital Spending-$11M–

Income Statement

MetricCAPRCLYM
Operating Income-$135M-$67M
Net Income-$129M-$59M
R&D Expense$100M$44M

Dividend & Shareholder Information

MetricCAPRCLYM
Shares Outstanding58M57M
EPS Growth–-495.4%
FAQ

CAPR vs CLYM: stock comparison and AI forecast

Which is bigger, CAPR or CLYM?

CAPR and CLYM have similar market capitalizations ($500M and $509M).

Which one does Intratio's AI model rank higher, CAPR or CLYM?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.